BiotechTube
Home/MapLight Therapeutics/Bernard Silverman
BS

Bernard Silverman

Clinical Advisory Board

MapLight Therapeutics

Therapeutic Areas

Autism Spectrum DisorderSchizophreniaParkinson's DiseaseAlzheimer's Disease Psychosis

MapLight Therapeutics Pipeline

DrugIndicationPhase
ML-007Schizophrenia (negative symptoms)Phase 2
ML-004Autism Spectrum Disorder (ASD)Phase 1
UndisclosedParkinson's DiseasePreclinical

Leadership Team at MapLight Therapeutics

CK
Christopher Kroeger
Chief Executive Officer, Founder, Board Member
EP
Erin Pennock Foff
Chief Medical Officer
JL
James Lillie
Chief Scientific Officer
AK
Anatol Kreitzer
Chief Discovery Officer
VS
Vishwas Setia
Chief Financial Officer
JG
Jonathan Gillis
Chief Administrative and Accounting Officer
KH
Kris Hanson
General Counsel
KD
Karl Deisseroth
Founder, Scientific Advisory Board
RM
Robert Malenka
Founder, Board Member, Scientific Advisory Board
KN
Karoly Nikolich
Chairman at Alkahest, Inc., Founder
View full MapLight Therapeutics profile